Medical News

RSS

Phase 3 clinical trial results of RG1068 to be discussed

Repligen Corporation announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will host a conference call and webcast on Wednesday, December 9th, 2009 at 8:30 a.m. EST, to discuss results of its Phase 3 clinical trial of RG1068 in MRI imaging of the pancreas.

9 Dec 2009

Research article addresses the relationship between PEG and GER

Gastroesophageal reflux (GER) is a common problem in mechanically ventilated patients and contributes to the development of esophageal mucosal injury and even erosive esophagitis. The relationship between percutaneous endoscopic gastrostomy (PEG) and subsequent development of GER is complex and not well understood.

9 Dec 2009

New drug designed to stop cancer from spreading by preventing mitosis

TGen Clinical Research Services at Scottsdale Healthcare (TCRS) is the world's first clinical trials site for a new drug designed to halt cancer cell division.

9 Dec 2009

FRC: Taxpayers to foot the bill for abortion-on-demand

This evening, the Nelson-Hatch abortion anti-funding amendment to the "Patient Protection and Affordable Care Act" was "tabled" by a vote of 54-45, thus killing any hope to make the health care bill abortion neutral. The Nelson-Hatch amendment would have prevented government funding for elective abortion in the public option or subsidies for health plans in the government run exchange that cover elective abortion.

9 Dec 2009

New study focuses on chronic parental reactive negativity

Any parent knows that sometimes maintaining your cool with misbehaving children is a challenge. We all have times when we get frustrated or angry and lash out at someone without thinking. A new study by psychologists at Virginia Tech and two other universities suggests that parents with poorer working memory skills are less likely to be able to control their emotions with their children.

9 Dec 2009

Laser technique used to change metal colors could have important implications for medicine

University of Rochester optics professor Chunlei Guo made headlines in the past couple of years when he changed the color of everyday metals by scouring their surfaces with precise, high-intensity laser bursts.

9 Dec 2009

No co-pays for patients enrolled in AstraZeneca's Medicare Part D prescription savings program

AstraZeneca announced today that patients enrolled in the company's Medicare Part D prescription savings program will no longer pay co-pays for their medicines through the program.

9 Dec 2009

Rats exposed to passive smoking become dependent on nicotine, reveals study

Rats passively exposed to tobacco smoke become dependent on nicotine, according to a new study by Dr. Adrie Bruijnzeel and colleagues from the University of Florida in the US. Their findings of how rats' brains respond to exposure to tobacco smoke have implications for the study of the effects of tobacco smoke on the human brain even from passive exposure to other smokers, and for future studies testing new treatments for tobacco addiction. Their work has just been published online in Springer's journal Psychopharmacology.

9 Dec 2009

TECHGENE project: CLC bio selected as software partner

Today the EU project, TECHGENE, that focuses on developing Next Generation Sequencing (NGS) diagnostic tools for genetic disorders, announced that CLC bio has been selected as the software partner for this project.

9 Dec 2009

High-flow oxygen appears to be more effective in treating cluster headaches

Patients with a cluster headache, which is characterized by bouts of excruciating pain usually near the eye or temple, were more likely to report being pain-free within 15 minutes of treatment with high-flow oxygen than patients who received a placebo treatment, according to a study in the December 9 issue of JAMA.

9 Dec 2009

New report on traditional European foods and recipe cards published

A new report on traditional European foods and a series of accompanying recipe cards have been published by The British Nutrition Foundation, on behalf of the European Food Information Resource (EuroFIR) project, a world-leading European Network of Excellence on food composition databank systems, to give an overview of traditional foods eaten in European countries.

9 Dec 2009

Scientists discuss sex lives of fruit flies

Females can be too attractive to the opposite sex -- too attractive for their own good -- say biologists at UC Santa Barbara. They found that, among fruit flies, too much male attention directed toward attractive females leads to smaller families and, ultimately, to a reduced rate of population-wide adaptive evolution.

9 Dec 2009

Human blood stem cells can be engineered to kill HIV and other chronic viral diseases

Researchers from the UCLA AIDS Institute and colleagues have for the first time demonstrated that human blood stem cells can be engineered into cells that can target and kill HIV-infected cells - a process that potentially could be used against a range of chronic viral diseases.

9 Dec 2009

Recruitment complete in Oxagen's OC000459 IIb clinical trial for asthma

Oxagen Limited, a drug discovery and development company specializing in inflammation, today announced that the recruitment for its double blind, randomised, placebo controlled Phase IIb clinical trial in asthma with OC000459, its lead oral CRTH2 (DP2) antagonist, has now been completed.

9 Dec 2009

Research study on breast cancer susceptibility in rats

Social isolation and stress appear to increase susceptibility to breast cancer in rats, a US study has suggested.

9 Dec 2009

Report highlights the state of oral health for children and adults in the United States

Oral disease, primarily dental caries, is the most common pediatric disease and can lead to physical and psychological disabilities as well as significant morbidity in adulthood.

9 Dec 2009

Research article on Peliosis hepatis

Peliosis hepatis (PH) is a rare pathological entity. PH varies from minimal asymptomatic lesions to larger massive lesions that may present with cholestasis, liver failure, portal hypertension, avascular mass lesion, or even spontaneous rupture.

9 Dec 2009

CSC's stem cell-derived motor neuron product for SMA receives FDA orphan drug designation

California Stem Cell, Inc. (CSC) and Families of Spinal Muscular Atrophy (FSMA) announced today that the FDA has granted orphan drug designation to MOTORGRAFT™, a stem cell-derived motor neuron product, for the treatment of Spinal Muscular Atrophy (SMA).

9 Dec 2009

European markets for Parkinson's disease therapeutics to reach $2.28 billion in 2015

The Parkinson's disease therapeutics market in 2008 amounted to over $1 billion in the European Union (EU), which includes total sales of carbidopa/levodopa, dopamine agonists, MAO-B inhibitors, COMT inhibitors and anticholinergics used for disease symptom relief.

9 Dec 2009

New Acesis software platform improves patient safety and quality care

Acesis, the enterprise software company focused on healthcare performance improvement, today announced results from its first six months of service for the University of California, San Francisco (UCSF) Division of Hospital Medicine.

9 Dec 2009